“…Matrix composition, stiffness, diffusion limitations, and vasculature are the primary contributors to drug resistance caused by the physical attributes of the ECM. In the case of CAM‐DR, the binding of cancer and/or stromal cells to ECM ligands such as collagens and fibronectin alters the mechanical properties of the matrix and can activate pro‐survival pathways, most commonly mediated by β1 integrins (Chiaretti, Astro, Chiricozzi, & de Curtis, 2016; Dittmer & Leyh, 2015; Park et al, 2006). SFM‐DR is caused by growth factors, proteins, proteases, and cytokines secreted by cancer‐associated fibroblasts (CAFs), mesenchymal stem cells (MSCs), or tumor‐associated macrophages.…”